When people talk about the FDA approval process, the conversation usually splits in two directions. One side argues it takes too long. The other argues it exists for a reason. Both are right. The challenge isn’t choosing between speed and safety. It’s understanding that the FDA approval process is designed to manage risk in a system where the consequences of getting it wrong are significant. That makes the balance more complicated than most headlines suggest.

For decades, we’ve known Medicare’s financial challenges were coming. The math hasn’t changed. The program continues to spend more than it brings in, and the demographic reality is unavoidable: more retirees, fewer workers, and escalating healthcare costs.

Across the country, the cost of living looks very different. What it takes to live in New York City isn’t the same as what it takes to live in Charlotte. But when it comes to federal tax deductions, Medicare policy, and national funding structures, we often treat every place and every taxpayer as if they’re operating in the same economy...